Spectral MD Holdings, Ltd.
("Spectral MD" or the "Company")
Publication of Annual Financial Report
LONDON, U.K. AND DALLAS, TX, U.S. - Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that the Annual Report and Accounts for 2022 are now available on the Company's website and have been posted to those shareholders who opted to receive hard copies of the Annual Report.
The Annual Report is available here: https://investors.spectralmd.com/financials/annual-interim-reports
For further information please contact:
| Spectral MD Holdings, Ltd. | investors.spectralmd.com | ||
| Wensheng Fan, Chief Executive Officer | via Walbrook PR | ||
| Nils Windler, Chief Financial Officer |
| ||
|
|
| ||
| SP Angel Corporate Finance LLP (NOMAD and Joint Broker) | Tel: +44 (0)20 3470 0470 | ||
| Stuart Gledhill/Harry Davies-Ball (Corporate Finance) Vadim Alexandre/Rob Rees (Sales & Broking)
|
| ||
| Stifel Nicolaus Europe Limited (Joint Broker) Charles Hoare / Ben Maddison / Nick Harland Will Palmer-Brown | Tel: +44 (0)20 7710 7600 | ||
|
|
| ||
| Walbrook PR Ltd (Media & Investor Relations) | Tel: +44 (0)20 7933 8780 or spectralMD@walbrookpr.com | ||
| Paul McManus / Louis Ashe-Jepson / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7747 515 393 +44 (0)7407 804 654 | ||
About Spectral MD:
We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView® Wound Imaging System.
www.spectralmd.com
info@spectralmd.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.